References
- Kilicdag EB, Yavuz H, Bagis T, Tarim E, Erkan AN, Kazanci F. Effects of estrogen therapy on hearing in postmenopausal women. Am J Obstet Gynecol 2004;190:77–82.
- Guimaraes P, Frisina ST, Mapes F, Tadros SF, Frisina DR, Frisina RD. Progestin negatively affects hearing in aged women. Proc Natl Acad Sci USA 2006;103:14246–9.
- Price K, Zhu X, Guimaraes PF, Vasilyeva ON, Frisina RD. Hormone replacement therapy diminishes hearing in peri-menopausal mice. Hear Res 2009;252:29–36.
- Hederstierna C, Hultcrantz M, Collins A, Rosenhall U. Hearing in women at menopause. Prevalence of hearing loss, audiometric configuration and relation to hormone replacement therapy. Acta Otolaryngol 2007;127:149–55.
- Snihur AW, Hampson E. Oral contraceptive use in women is associated with defeminization of otoacoustic emission patterns. Neuroscience 2012;210:258–65.
- Hederstierna C, Hultcrantz M, Collins A, Rosenhall U. The menopause triggers hearing decline in healthy women. Hear Res 2010;259:31–5.
- Coleman JR, Campbell D, Cooper WA, Welsh MG, Moyer J. Auditory brainstem responses after ovariectomy and estrogen replacement in rat. Hear Res 1994;80:209–15.
- Stenberg AE, Wang H, Sahlin L, Hultcrantz M. Mapping of estrogen receptors alpha and beta in the inner ear of mouse and rat. Hear Res 1999;136:29–34.
- Simonoska R, Stenberg AE, Duan M, Yakimchuk K, Fridberger A, Sahlin L, et al. Inner ear pathology and loss of hearing in estrogen receptor-beta deficient mice. J Endocrinol 2009;201:397–406.
- Gungor N, Boke B, Belgin E, Tuncbilek E. High frequency hearing loss in Ullrich-Turner syndrome. Eur J Pediatr 2000;159:740–4.
- Johannesson U, Sahlin L, Masironi B, Hilliges M, Blomgren B, Rylander E, et al. Steroid receptor expression and morphology in provoked vestibulodynia. Am J Obstet Gynecol 2008;198:311.e1–6.
- Sahlin L, Masironi B, Akerberg S, Eriksson H. Tissue- and hormone-dependent progesterone receptor distribution in the rat uterus. Reprod Biol Endocrinol 2006;4:47.
- Bland R. Steroid hormone receptor expression and action in bone. Clin Sci 2000;98:217–40.
- Mote PA, Johnston JF, Manninen T, Tuohimaa P, Clarke CL. Detection of progesterone receptor forms A and B by immunohistochemical analysis. J Clin Pathol 2001;54:624–30.
- Kakar M, Kanwal C, Davis JR, Li H, Lim CS. Geldanamycin, an inhibitor of Hsp90, blocks cytoplasmic retention of progesterone receptors and glucocorticoid receptors via their respective ligand binding domains. AAPS J 2006;8:E718–28.
- Erichsen S, Bagger-Sjoback D, Curtis L, Zuo J, Rarey K, Hultcrantz M. Appearance of glucocorticoid receptors in the inner ear of the mouse during development. Acta Otolaryngol 1996;116:721–5.
- Lang F, Vallon V, Knipper M, Wangemann P. Functional significance of channels and transporters expressed in the inner ear and kidney. Am J Physiol Cell Physiol 2007;293:C1187–208.
- Pang Y, Dong J, Thomas P. Characterization, neurosteroid binding and brain distribution of human membrane progesterone receptors delta and {epsilon} (mPRdelta and mPR{epsilon}) and mPRdelta involvement in neurosteroid inhibition of apoptosis. Endocrinology 2013;154:283–95.